In cancer patients with insulin resistance, the elevated levels of circulating insulin accompanied frequently by insulin receptor (IR) overexpression in cancer cells may be associated with atypical stimulation of non-metabolic effects of IR, including cell proliferation, migration, and survival. This evidence concerns the gene INSR and cancer.